MIRA INFORM REPORT

 

 

Report Date :

30.10.2014

 

IDENTIFICATION DETAILS

 

Name :

ANUH PHARMA LIMITED

 

 

Registered Office :

A-3, Shivsagar Estate, North Wing, Dr. Annie Besant Road, Worli, Mumbai – 400018, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

19.02.1960

 

 

Com. Reg. No.:

11-011586

 

 

Capital Investment / Paid-up Capital :

Rs. 41.760 Millions

 

 

CIN No.:

[Company Identification No.]

L24230MH1960PLC011586

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA22404E / MUMA20261D

 

 

PAN No.:

[Permanent Account No.]

AAACA4478P

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Bulk Drugs and Chemicals.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2400000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having fine track record.

 

Financial position of the company seems to be sound.

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be regular and as per commitments.

 

The company can be considered normal for normal business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had illfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Long term Cash Credit = BBB+

Rating Explanation

Have moderate degree of safety and carry moderate credit risk.

Date

June 2014

 

 

Rating Agency Name

ICRA

Rating

Short term Non-fund based = A2+

Rating Explanation

Have strong degree of safety and carry low credit risk. 

Date

June 2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DECLINED

 

MANAGEMENT NON CO-OPERATIVE (91-22-66227575)

 

LOCATIONS

 

Registered/ Corporate Office :

A-3, Shivsagar Estate, North Wing, Dr. Annie Besant Road, Worli, Mumbai – 400018, Maharashtra, India

Tel. No.:

91-22-66227575/ 55527575

Fax No.:

91-22-55527600/ 66227500

E-Mail :

anuh@skageexport.com

anuh@sk1932.com

info@sk1932.com

Website :

http://www.anuhpharma.com

 

 

Factory 1 :

Anuh Pharma

E-17/3 and 17/4, M.I.D.C. Tarapur, Boisar, District Thane - 401506, Maharashtra, India

Tel. No.:

91-2525-272174/ 270281

Fax No.:

91-2525-270281

E-Mail :

ritesh@sk1932.com

 

 

Factory 2 :

Eskay Fine Chemicals

Turbhe Thane Belapur Road, Navi Mumbai – 400705, Maharashtra, India

Telefax :

91-22-27681505/ 27681708

E-Mail :

anita@sk1932.com

 

 

R & D Division :

A-514, TTC Industrial Area, MIDC, Mahape, Navi Mumbai – 400701, Maharashtra, India

 

 

DIRECTORS

 

As on 02.08.2013

 

Name :

Mr. Jayantilal Popatlal Shah

Designation :

Director

Address :

Flat No. 3B, 31D Floor, New Suvas A, 68-F, Nepeansea Road, Malabar Hill, Mumbai - 400 006, Maharashtra, India

Date of Birth/Age :

07.05.1929

Date of Appointment :

29.10.1980

DIN No.:

00083146

 

 

Name :

Mr. Lalitkumar Popatlal Shah

Designation :

Director

Address :

B-212, Amalfi, 27B, L.D. Ruparel Marg, Malabar Hill, Mumbai - 400 006 Maharashtra, India

Date of Birth/Age :

02.10.1936

Date of Appointment :

29.10.1980

DIN No.:

00396345

 

 

Name :

Mr. Bharat Nemchand Shah

Designation :

Director

Address :

4'h Floor, Room No. 15, Bhartiya Bhavan, Netaji Subhash Road, Marine Drive, Mumbai - 400 020 Maharashtra, India

Date of Birth/Age :

06.09.1946

Date of Appointment :

29.10.1980

DIN No.:

00083354

PAN No.:

ADUPS8329M

 

 

Name :

Mr. Bipin Nemchand Shah

Designation :

Managing Director

Address :

180 1 Devdarshan, 50 Ridge Road, Teen Batti, Mumbai - 400 006 Maharashtra, India

Date of Birth/Age :

07.03.1949

Date of Appointment :

04.09.1987

DIN No.:

00083244

PAN No.:

AACPS5406N

 

 

Name :

Mr. Jasvantlal Girdharilal Shah

Designation :

Director

Address :

5711439, Adarsh Nagar, Prabhadevi, Dadar, Mumbai 400025 Maharashtra, India

Date of Birth/Age :

24.11.1933

Date of Appointment :

09.08.1995

DIN No.:

00372600

 

 

Name :

Mr. Dilip Shah

Designation :

Director

Address :

2/21 Beach Queen, 35b Azad Road, Juhu, Mumbai- 400049 Maharashtra, India

Date of Birth/Age :

25.04.1941

Date of Appointment :

30.10.2007

DIN No.:

01989812

 

 

Name :

Mr. Arun Todarwal

Designation :

Director

Address :

81, Shiner, 84, Nepean Sea Road, Mumbai, 400006, Maharashtra, India

Date of Birth/Age :

16.06.1957

Date of Appointment :

24.10.2008

DIN No.:

00020916

 

 

Name :

Mr. Sandeep Madhusudan Joshi

Designation :

Director

Address :

202 kasturi towers 238A, Lbs Marg opp Red Cross Bhavan Thane, Thane-400602, Maharashtra, India

Date of Birth/Age :

01.01.1961

Date of Appointment :

09.11.2012

DIN No.:

00516409

 

 

Name :

Mr. Gulabchand Sharda

Designation :

Director

Address :

604 Swaroop Co Op. Hsg. SOC. Ltd., Near Bhakti Mandir, Panchpakhadi, Thane (West), Thane-400602, Maharashtra, India

Date of Birth/Age :

20.04.1944

Date of Appointment :

24.05.2013

DIN No.:

06583340

PAN No.:

AAMPS9620C

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2014

 

Category of Shareholder

Total No. of Shares

As a %

(A) Shareholding of Promoter and Promoter Group

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

5252854

62.89

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

174804

2.09

http://www.bseindia.com/include/images/clear.gifGroup Companies

174804

2.09

http://www.bseindia.com/include/images/clear.gifSub Total

5427658

64.99

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

5427658

64.99

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

225685

2.70

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

1920819

23.00

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

743741

8.90

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

34097

0.41

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

24882

0.30

http://www.bseindia.com/include/images/clear.gifClearing Members

8447

0.10

http://www.bseindia.com/include/images/clear.gifDirectors & their Relatives & Friends

768

0.01

http://www.bseindia.com/include/images/clear.gifSub Total

2924342

35.01

Total Public shareholding (B)

2924342

35.01

Total (A)+(B)

8352000

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

8352000

0.00

 

 

 

As on 02.08.2013

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Bodies corporate

4.05

Directors or relatives of Directors

62.92

Other top fifty shareholders

14.77

Others

17.98

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs and Chemicals.

 

 

Products :

ITC Code No.

 

Product Descriptions

2941.50

Erythromycin Salts

2941.40

Chloramphenicol

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

Bank of India, Mumbai MID Corporate, 70/80, M.G. Road, Bank of India Building, Mezzanine Floor, Fort, Mumbai - 400001, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2014

As on

31.03.2013

SHORT TERM BORROWINGS

 

 

From Bank

Overdraft from Bank of India

(Secured by lien on fixed deposit with bank)

0.000

5.237

Total

0.000

5.237

 

 

 

Banking Relations :

---

 

 

Auditors :

 

Name :

S.I. Mogul and Company

Chartered Accountants

Address :

73-B, Mittal Court, Nariman Point, Mumbai – 400021, Maharashtra, India

PAN No.:

AAMFS7435P

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives

  • S Kant Healthcare Limited
  • S.K. Age Exports
  • S Kant Chemicals Private Limited
  • S Kant Pharma Private Limited
  • Eskay Iodine Private Limited
  • Eskay Speciality Chemicals
  • Sevantilal Kantilal & Company

 

 

CAPITAL STRUCTURE

 

As on 02.08.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20,000,000

Equity Shares

Rs. 5/- each

Rs.100.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

8,352,000

Equity Shares

Rs. 5/- each

Rs. 41.760 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

41.760

41.760

41.760

(b) Reserves & Surplus

817.053

714.475

650.298

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

858.813

756.235

692.058

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

2.445

2.580

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

2.559

2.135

1.153

Total Non-current Liabilities (3)

5.004

4.715

1.153

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

5.237

13.024

(b) Trade payables

600.184

469.542

294.352

(c) Other current liabilities

17.660

13.143

26.874

(d) Short-term provisions

150.928

112.408

162.880

Total Current Liabilities (4)

768.772

600.330

497.130

 

 

 

 

TOTAL

1632.589

1361.280

1190.341

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

120.550

104.025

74.894

(ii) Intangible Assets

0.985

0.773

0.304

(iii) Capital work-in-progress

1.780

25.980

34.280

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

80.286

55.790

250.618

(c) Deferred tax assets (net)

0.000

0.000

1.170

(d)  Long-term Loan and Advances

13.285

9.270

6.686

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

216.886

195.838

367.952

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

188.000

138.022

75.125

(b) Inventories

193.245

236.843

125.921

(c) Trade receivables

747.472

544.361

390.885

(d) Cash and cash equivalents

154.713

133.767

66.430

(e) Short-term loans and advances

129.918

110.033

163.236

(f) Other current assets

2.356

2.416

0.792

Total Current Assets

1415.704

1165.442

822.389

 

 

 

 

TOTAL

1632.590

1361.280

1190.341

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

2663.977

2426.707

2256.786

 

 

Other Income

41.487

22.275

30.099

 

 

TOTAL                                     (A)

2705.464

2448.982

2286.885

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

2099.306

1968.956

1821.004

 

 

Purchases of Stock-in-Trade

8.289

59.410

101.125

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

35.147

(27.523)

(35.098)

 

 

Employees benefits expense

46.658

46.790

32.009

 

 

Other expenses

242.799

207.412

169.144

 

 

TOTAL                                     (B)

2432.199

2255.045

2088.184

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

273.265

193.937

198.701

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

1.039

0.453

4.986

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

272.226

193.484

193.715

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

17.461

16.636

13.215

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

254.765

176.848

180.500

 

 

 

 

 

Less

TAX                                                                  (H)

78.865

51.498

52.039

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

175.900

125.350

128.461

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

155.896

141.720

113.021

 

 

 

 

 

Add

Income Tax adjustment of earlier years

2.407

(2.545)

3.626

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

50.000

50.000

50.000

 

 

Proposed final Dividend

54.288

50.112

45.936

 

 

Tax on proposed final Dividend

11.000

8.517

7.452

 

 

Interim Dividend

10.440

0.000

0.000

 

BALANCE CARRIED TO THE B/S

208.475

155.896

141.720

 

 

 

 

 

 

Earnings Per Share (Rs.)

21.06

15.01

15.38

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

PAT / Total Income

(%)

6.50

5.12

5.62

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

9.56

7.29

8.00

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

16.43

13.82

19.96

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.30

0.23

0.26

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.01

0.02

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.84

1.94

1.65

 

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

41.760

41.760

41.760

Reserves & Surplus

650.298

714.475

817.053

Net worth

692.058

756.235

858.813

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

13.024

5.237

0.000

Total borrowings

13.024

5.237

0.000

Debt/Equity ratio

0.019

0.007

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2256.786

2426.707

2663.977

 

 

7.529

9.777

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2256.786

2426.707

2663.977

Profit

128.461

125.350

175.900

 

5.69%

5.17%

6.60%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

No

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

OPERATIONS

 

The sales and operating income for the year ended 31st March 2014 amounted to Rs. 2649.279 Millions as against Rs. 2416.049 Millions for the previous year. Thus the turnover of the company has increased by about 9.65% as compared to last year’s turnover.

 

During the year 2013-14 profit before tax as compared to last year has increased by 41.14% from Rs. 180.500 Millions to Rs. 254.765 Millions and profit after tax has increased by 40.33% from Rs. 125.350 Millions to Rs. 175.899 Millions.

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

 

Charge Holder

Address

Service Request Number (SRN)

1

10038218

22/03/2012 *

650,000,000.00

BANK OF INDIA

MUMBAI MID CORPORATE, 70/80, M.G. ROAD, BANK OF INDIA BUILDING, MEZZANINE FLOOR, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B38298881

2

90186656

20/03/1999

2,500,000.00

BANK OF INDIA

OPERA HOUSE BRANCH; HERMES HOUSE, MAMA PARAMANAND ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

3

90186448

23/04/1997

2,000,000.00

BANK OF INDIA

OPERA HOUSE BRANCH; HERMES HOUSE, MAMA PARAMANAND ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

4

90184014

14/06/2010 *

450,000,000.00

BANK OF INDIA

WORLI NAKA BR., PANKAJ MANSION, OPP. PODAR HOSPITAL, DR. A. B. ROAD, WORLI NAKA,, MUMBAI, MAHARASHTRA - 400018, INDIA

A91194704

5

90185621

23/04/1997 *

1,200,000.00

BANK OF INDIA

OPERA HOUSE BRANCH; HERMES HOUSE, MAMA PARAMANAND ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

6

90187519

23/04/1997 *

4,000,000.00

BANK OF INDIA

OPERA HOUSE BRANCH; HERMES HOUSE, MAMA PARAMANAND ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

7

90185390

29/07/1992 *

3,300,000.00

BANK OF INDIA

OPERA HOUSE BRANCH; HERMES HOUSE, MAMA PARAMANAND ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

8

90187464

06/10/1995 *

3,300,000.00

BANK OF INDIA

OPERA HOUSE BRANCH; HERMES HOUSE, MAMA PARAMANAND ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

9

90183919

08/02/1991 *

4,500,000.00

BANK OF INDIA

OPERA HOUSE BRANCH; HERMES HOUSE, MAMA PARAMANAND ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

10

90187389

08/01/1987

300,000.00

CANARA BANK

QUEEN'S ROAD, BOMBAY, MAHARASHTRA - 400004, INDIA

-

 

* Date of charge modification

 

 

FIXED ASSETS

 

Tangible Assets

·         Leasehold Land

·         Buildings

·         Plant and Machinery

·         Laboratory Equipments

·         Material Storage and Handling Equipments

·         Electric Installations

·         Airconditioning Equipments and Refrigarators

·         Computer Hardware

·         Furniture and Fixtures

·         Vehicles

·         Office equipment

 

Intangible Assets

·         Computer software

 

 

UNAUDITED FINANCIAL RESULT FOR THE QUARTER & YEAR ENDED ON 30TH JUN 2014

Rs. In Millions

Sr.

No.

Particulars

Quarter Ended

 

 

Jun-14

1

Net Sales / Income From Operation

                 753.370

2

Expenditure

 

 

a

(Increase)/Decrease in Stock

 (40.708)

 

B

Cost of Materials Consumed

                 629.181

 

c

Purchase of Stock -in-Trade

                        -

 

d

Employees Benefit Expense

                    4.157

 

e

Processing Charges

                    7.863

 

f

Power Fuel & Other Utility

                    8.445

 

g

Depreciation

                    4.500

 

h

Other Expenses

                   38.388

 

 

Total : -

                671.825

3

Profit From Operation before Finance Cost & Exceptional Item (1-2)

                   81.544

4

A

Other Income

                   14.094

 

b

Exchange Gain/(Loss)

                   (1.947)

5

Profit before Interest &  Exceptional Items(3+4)

                   93.691

6

Finance Cost

                     0.068

7

Profit after Interest but before Exceptional Item(5-6)

                   93.623

8

Exceptional Item

                        -

9

Profit(+) / Loss(-) before Tax (7+8)

                   93.623

10

Tax Expenses

                   28.000

11

Net Profit(+) / Loss(-) from Ordinary Activities after Tax (9-10)

                   65.623

12

Extraordinary Item (Net of Tax Expenses)

                        -

13

Net Profit(+) / Loss(-)  for the period (11-12)

                   65.623

14

Paid up Equity Share Capital

                   41.760

15

Reserves excluding Revolution Reserves as per Balance sheet of

Previous Accounting Year

                            

16

Earning per Share(EPS) Face Value of Rs.5/-

 

 

a

Basic & Diluted EPS before Extraordinary items for the period, for the year to date and for the previous year

(not to be annualised)

                      7.86

 

 

 

 

 

 

 

b

Basic & Diluted EPS after Extraordinary items for the period, for the year to date and for the previous year

(not to be annualised)

                      7.86

 

 

 

 

 

 

A

PARTICULARS OF SHAREHOLDING

 

1

Public Shareholding

 

 

 

Number of Shares

              2,918,162

 

 

Percentage of Shareholding

                    34.94

2

Promoters & Promoter group Shareholding

 

 

a

Pledged/Encumbered

 

 

 

 -Number of Shares

Nil

 

 

 -Percentage of Shares(as a % of the total shareholding of promoters and promoter group)

 

 

 

 

 

 

 -Percentage of shares( as a % of the total share capital of the company)

 

 

 

 

 

b

Non Encumbered

 

 

 

 -Number of Shares

              5,433,838

 

 

 -Percentage of Shares(as a % of the total shareholding of promoters and promoter group)

                   100.00

 

 

 

 

 

 -Percentage of shares( as a % of the total share capital of the company)

                    65.06

B

INVESTOR COMPLAINTS

 

 

Pending at the begining of the quarter

0

 

Received during the quarter

1

 

Disposed of during the quarter

1

 

Remaining unresolved at the end of the quarter

0

 

Note:

 

  1. The above results were taken an record by the Board of Directors of the Company at their meeting held on 13th August -2014
  2. The Company's operation fall under single segment namely "Bulk Drugs & Chemicals".

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.32

UK Pound

1

Rs.99.00

Euro

1

Rs.78.14

 

 

INFORMATION DETAILS

 

Information Gathered by :

HET

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

NTH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.